Показать сокращенную информацию
Hemolytic disease of newborns
| dc.contributor.author | Kasyanova, A. R. | |
| dc.contributor.author | Alferovich, E. N. | |
| dc.contributor.author | Cocorina, N. V. | |
| dc.date.accessioned | 2025-09-23T13:11:31Z | |
| dc.date.available | 2025-09-23T13:11:31Z | |
| dc.date.issued | 2024 | |
| dc.identifier.uri | https://rep.bsmu.by/handle/BSMU/51484 | |
| dc.description | Kasyanova, A. R. Hemolytic disease of newborns / A. R. Kasyanova, E. N. Аlferovich, N. V. Cocorina // Actual environmental problems : proc. of the XIV Intern. Sci. Conf. of young scientists, graduates, master and PhD students, Minsk, 5–6 Dec. 2024 / Belarus. State Univ., Establishment of Education «International Sakharov Environmental Institute». – Minsk, 2024. – P. 171–173. | ru_RU |
| dc.description.abstract | The article discusses erythroblastosis or hemolytic disease of newborns (GBN) – a prenatal pathology due to incompatibility of fetal and maternal blood by Rho(D) antigen and AB0 system. In the mother's body, antibodies directed against the child's red blood cells cause hemolysis or a sharp inhibition of their formation. Hemolytic anemia of the fetus as a result of Rh factor incompatibility can lead to serious complications or death in the prenatal period. In this regard, the prevention and treatment of GBH in newborns requires a specialized approach. The urgency of the problem of hemolytic diseases of newborns is due to the frequency of development, the severity of the course and complications leading to the death of the fetus or newborn | ru_RU |
| dc.language.iso | en | ru_RU |
| dc.title | Hemolytic disease of newborns | ru_RU |
| dc.type | Article | ru_RU |
